National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

maytansinoid DM4-conjugated humanized monoclonal antibody huC242 (may-TAN-sih-noyd DM4-KON-juh-GAY-ted HYOO-muh-nized MAH-noh-KLOH-nul AN-tee-BAH-dee...)

 A substance being studied in the treatment of some types of cancer. It is made by linking the monoclonal antibody huC242 to a toxic substance called maytansinoid DM4. The monoclonal antibody locates and binds to the surfaces of cancer cells and the maytansinoid DM4 enters the cells and blocks their growth. It is a type of immunotoxin. Also called huC242-DM4.



Previous Definitions:matuzumab, Maxamine, maxillary sinus, maximum inspiratory pressure test, maximum tolerated dose
Next Definitions:MBL, MC1R, MDL 101,731, MDR modulator CBT-1, MDX-010

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov